Akebia Therapeutics Inc (AKBA)
1.81
+0.02
(+1.12%)
USD |
NASDAQ |
Nov 21, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 30, 2023 | 19.84 |
| March 29, 2023 | 21.31 |
| March 28, 2023 | 21.11 |
| March 27, 2023 | 23.12 |
| March 24, 2023 | 22.50 |
| March 23, 2023 | 24.15 |
| March 22, 2023 | 23.52 |
| March 21, 2023 | 24.66 |
| March 20, 2023 | 23.85 |
| March 17, 2023 | 22.36 |
| March 16, 2023 | 25.10 |
| March 15, 2023 | 23.66 |
| March 14, 2023 | 24.07 |
| March 13, 2023 | 26.61 |
| March 10, 2023 | 28.15 |
| March 09, 2023 | 28.21 |
| March 08, 2023 | 36.29 |
| March 07, 2023 | 33.31 |
| March 06, 2023 | 33.19 |
| March 03, 2023 | 34.00 |
| March 02, 2023 | 32.69 |
| March 01, 2023 | 32.23 |
| February 28, 2023 | 29.69 |
| February 27, 2023 | 28.73 |
| February 24, 2023 | 29.07 |
| Date | Value |
|---|---|
| February 23, 2023 | 26.07 |
| February 22, 2023 | 24.38 |
| February 21, 2023 | 23.04 |
| February 17, 2023 | 30.93 |
| February 16, 2023 | 30.40 |
| February 15, 2023 | 31.22 |
| February 14, 2023 | 29.94 |
| February 13, 2023 | 27.94 |
| February 10, 2023 | 28.27 |
| February 09, 2023 | 39.46 |
| February 08, 2023 | 40.51 |
| February 07, 2023 | 39.81 |
| February 06, 2023 | 37.69 |
| February 03, 2023 | 34.74 |
| February 02, 2023 | 31.35 |
| February 01, 2023 | 23.60 |
| January 31, 2023 | 22.19 |
| January 30, 2023 | 21.27 |
| January 27, 2023 | 23.59 |
| January 26, 2023 | 25.00 |
| January 25, 2023 | 25.07 |
| January 24, 2023 | 25.43 |
| January 23, 2023 | 25.01 |
| January 20, 2023 | 25.94 |
| January 19, 2023 | 24.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8856
Minimum
Sep 29 2022
40.51
Maximum
Feb 08 2023
4.645
Average
2.818
Median
Aug 30 2021
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 9.178 |
| Eli Lilly and Co | 49.99 |
| Bioventus Inc | 5.063 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.171 |
| Price | 1.81 |
| Earnings Yield | -12.53% |
| Market Cap | 394.91M |